These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 23377638)

  • 21. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder.
    Copeland WE; Shanahan L; Egger H; Angold A; Costello EJ
    Am J Psychiatry; 2014 Jun; 171(6):668-74. PubMed ID: 24781389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Correlates of Disruptive Mood Dysregulation Disorder Among Adolescents with Bipolar Disorder.
    Mitchell RH; Timmins V; Collins J; Scavone A; Iskric A; Goldstein BI
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):147-53. PubMed ID: 26844707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment.
    Canino G; Shrout PE; Rubio-Stipec M; Bird HR; Bravo M; Ramirez R; Chavez L; Alegria M; Bauermeister JJ; Hohmann A; Ribera J; Garcia P; Martinez-Taboas A
    Arch Gen Psychiatry; 2004 Jan; 61(1):85-93. PubMed ID: 14706947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Childhood and adolescent psychiatric disorders as predictors of young adult disorders.
    Copeland WE; Shanahan L; Costello EJ; Angold A
    Arch Gen Psychiatry; 2009 Jul; 66(7):764-72. PubMed ID: 19581568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder.
    Greene RW; Biederman J; Zerwas S; Monuteaux MC; Goring JC; Faraone SV
    Am J Psychiatry; 2002 Jul; 159(7):1214-24. PubMed ID: 12091202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in diagnosis of bipolar and disruptive mood dysregulation disorders in children and youth.
    Le J; Feygin Y; Creel L; Lohr WD; Jones VF; Williams PG; Myers JA; Pasquenza N; Davis DW
    J Affect Disord; 2020 Mar; 264():242-248. PubMed ID: 32056757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruptive mood dysregulation disorder: does variance in treatment responses also add to the conundrum? The widening gap in the evidence is a signal needing attention.
    Gupta M; Gupta N
    CNS Spectr; 2022 Dec; 27(6):659-661. PubMed ID: 34789360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of DSM-IV psychiatric disorders among adolescents in a large metropolitan area.
    Roberts RE; Roberts CR; Xing Y
    J Psychiatr Res; 2007 Dec; 41(11):959-67. PubMed ID: 17107689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temper Loss and Persistent Irritability in Preschoolers: Implications for Diagnosing Disruptive Mood Dysregulation Disorder in Early Childhood.
    Martin SE; Hunt JI; Mernick LR; DeMarco M; Hunter HL; Coutinho MT; Boekamp JR
    Child Psychiatry Hum Dev; 2017 Jun; 48(3):498-508. PubMed ID: 27510439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder.
    Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E
    J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First incidence, age of onset outcomes and risk factors of onset of DSM-5 oppositional defiant disorder: a cohort study of Spanish children from ages 3 to 9.
    Ezpeleta L; Navarro JB; de la Osa N; Penelo E; Domènech JM
    BMJ Open; 2019 Mar; 9(3):e022493. PubMed ID: 30928923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.
    Lavigne JV; Cicchetti C; Gibbons RD; Binns HJ; Larsen L; DeVito C
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1393-400. PubMed ID: 11765284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruptive Mood Dysregulation Disorder (DMDD): An RDoC perspective.
    Meyers E; DeSerisy M; Roy AK
    J Affect Disord; 2017 Jul; 216():117-122. PubMed ID: 27554606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation.
    Brotman MA; Kassem L; Reising MM; Guyer AE; Dickstein DP; Rich BA; Towbin KE; Pine DS; McMahon FJ; Leibenluft E
    Am J Psychiatry; 2007 Aug; 164(8):1238-41. PubMed ID: 17671287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruptive mood dysregulation disorder: a new diagnosis in the DSM-5.
    Johnson K; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2014 Feb; 52(2):17-20. PubMed ID: 24444386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demographic Differences in Disruptive Mood Dysregulation Disorder Symptoms in ADHD, Autism, and General Population Samples.
    Mayes SD; Calhoun SL; Waxmonsky JG; Kokotovich C; Baweja R; Lockridge R; Bixler EO
    J Atten Disord; 2019 Jun; 23(8):849-858. PubMed ID: 27549781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affective dysregulation in childhood - optimizing prevention and treatment: protocol of three randomized controlled trials in the ADOPT study.
    Döpfner M; Katzmann J; Hanisch C; Fegert JM; Kölch M; Ritschel A; Treier AK; Hellmich M; Roessner V; Ravens-Sieberer U; Banaschewski T; Görtz-Dorten A;
    BMC Psychiatry; 2019 Sep; 19(1):264. PubMed ID: 31477086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three dimensions of oppositionality in youth.
    Stringaris A; Goodman R
    J Child Psychol Psychiatry; 2009 Mar; 50(3):216-23. PubMed ID: 19166573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.